Parkinson's Disease Trial, Recruiting NCT07110376 Sponsor: The Cleveland Clinic Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07110376
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years of age, either male or female
  • People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's disease with no known cause)
  • People who have had a specific Medtronic brain stimulation device (called Percept PC) implanted on both sides of the brain, targeting an area called the subthalamic nucleus, and whose stimulation settings have been stable and optimised for at least three months
  • People who experience sleep disturbances related to their Parkinson's disease, as indicated by a score of one or higher on a specific question from a standard Parkinson's disease rating scale (confirm with trial site)
  • People who are able to walk around independently
  • People who are able to understand and agree to participate in the trial on their own
  • People who take sleep-related medications, provided the dose has remained unchanged for at least 30 days

Who may not be able to join:

  • People who have other neurological conditions in addition to Parkinson's disease, such as stroke or multiple sclerosis
  • People who have an active sleep disorder, such as narcolepsy, untreated moderate to severe sleep apnoea, or uncontrolled restless legs syndrome
  • People who have been formally diagnosed with dementia following a neuropsychological assessment
  • People who have a current alcohol or substance abuse problem
  • People who work night shifts or have irregular working hours

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 216 678-8896

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 November 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To demonstrate differences in sleep efficiency (SE) among different stimulation settings.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov